166 related articles for article (PubMed ID: 24312440)
1. Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome.
Zhang L; Wang T; Wang XQ; Du RZ; Zhang KN; Liu XG; Ma DX; Yu S; Su GH; Li ZH; Guan YQ; Du NL
PLoS One; 2013; 8(12):e71466. PubMed ID: 24312440
[TBL] [Abstract][Full Text] [Related]
2. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome.
Zhao Z; Wu Y; Cheng M; Ji Y; Yang X; Liu P; Jia S; Yuan Z
Atherosclerosis; 2011 Aug; 217(2):518-24. PubMed ID: 21524750
[TBL] [Abstract][Full Text] [Related]
3. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Peng D; Xu B; Wang Y; Guo H; Jiang Y
PLoS One; 2013; 8(7):e68446. PubMed ID: 23874630
[TBL] [Abstract][Full Text] [Related]
4. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.
Zhang L; Li YG; Li YH; Qi L; Liu XG; Yuan CZ; Hu NW; Ma DX; Li ZF; Yang Q; Li W; Li JM
PLoS One; 2012; 7(4):e31000. PubMed ID: 22485125
[TBL] [Abstract][Full Text] [Related]
5. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis.
Zhang L; Li JM; Liu XG; Ma DX; Hu NW; Li YG; Li W; Hu Y; Yu S; Qu X; Yang MX; Feng AL; Wang GH
J Clin Immunol; 2011 Aug; 31(4):606-14. PubMed ID: 21556937
[TBL] [Abstract][Full Text] [Related]
6. Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma.
Peng Z; Hu Y; Ren J; Yu N; Li Z; Xu Z
Int J Med Sci; 2021; 18(1):99-108. PubMed ID: 33390778
[TBL] [Abstract][Full Text] [Related]
7. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
8. Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.
Wang M; Chen P; Jia Y; He N; Li D; Ji C; Ma D
Oncotarget; 2015 Jul; 6(20):17958-67. PubMed ID: 26255628
[TBL] [Abstract][Full Text] [Related]
9. Role of Th1 and Th17 cells in the development and complexity of coronary artery disease: comparison analysis by the methods of flow cytometry and SYNTAX score.
Kim JD; Lee SH; Seo EH; Woo SY; Kim SH; Chung SM; Kim HJ
Coron Artery Dis; 2015 Nov; 26(7):604-11. PubMed ID: 26180995
[TBL] [Abstract][Full Text] [Related]
10. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J
Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787
[TBL] [Abstract][Full Text] [Related]
11. Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice.
Chai H; Yang L; Gao L; Guo Y; Li H; Fan X; Wu B; Xue S; Cai Y; Jiang X; Qin B; Zhang S; Ke Y
Transplantation; 2014 Oct; 98(7):729-37. PubMed ID: 25093516
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.
Liu T; Peng L; Yu P; Zhao Y; Shi Y; Mao X; Chen W; Cheng P; Wang T; Chen N; Zhang J; Liu X; Li N; Guo G; Tong W; Zhuang Y; Zou Q
J Clin Immunol; 2012 Dec; 32(6):1332-9. PubMed ID: 22760549
[TBL] [Abstract][Full Text] [Related]
13. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia.
Tian T; Sun Y; Li M; He N; Yuan C; Yu S; Wang M; Ji C; Ma D
Clin Chim Acta; 2013 Nov; 426():108-13. PubMed ID: 24064425
[TBL] [Abstract][Full Text] [Related]
14. Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients.
Ye J; Wang Y; Wang Z; Ji Q; Huang Y; Zeng T; Hu H; Ye D; Wan J; Lin Y
Mediators Inflamm; 2018; 2018():5697149. PubMed ID: 30258282
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
Luan L; Han S; Wang H; Liu X
Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971
[TBL] [Abstract][Full Text] [Related]
16. Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance.
Zhang L; Zhang J; Su S; Luo S
PeerJ; 2019; 7():e5652. PubMed ID: 30631648
[TBL] [Abstract][Full Text] [Related]
17. Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia.
Yu S; Liu C; Zhang L; Shan B; Tian T; Hu Y; Shao L; Sun Y; Ji C; Ma D
Int J Mol Sci; 2014 Jan; 15(2):1927-45. PubMed ID: 24473142
[TBL] [Abstract][Full Text] [Related]
18. The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia.
Chen P; Wang M; Li D; Jia Y; He N; Li W; Ma D; Ji C
J Immunol Res; 2015; 2015():416123. PubMed ID: 26000313
[TBL] [Abstract][Full Text] [Related]
19. Circulating Th22 and Th9 levels in patients with acute coronary syndrome.
Lin YZ; Wu BW; Lu ZD; Huang Y; Shi Y; Liu H; Liu L; Zeng QT; Wang X; Ji QW
Mediators Inflamm; 2013; 2013():635672. PubMed ID: 24453425
[TBL] [Abstract][Full Text] [Related]
20. Circulating Th17, Th22, and Th1 cells are increased in psoriasis.
Kagami S; Rizzo HL; Lee JJ; Koguchi Y; Blauvelt A
J Invest Dermatol; 2010 May; 130(5):1373-83. PubMed ID: 20032993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
